MB 1
BULLETS
Free CME
Please confirm topic selection

Are you sure you want to trigger topic in your Anconeus AI algorithm?

Please confirm action

You are done for today with this topic.

Would you like to start learning session with this topic items scheduled for future?

Review Question - QID 210719

Targeted Therapy Imatinib (Gleevec) Mechanism QID: 210719 (M1.OMB.18.1)
In scope icon N/A B
QID 210719 (Type "210719" in App Search)
A scientist is studying mechanisms by which cancer drugs work to kill tumor cells. She is working to optimize the function of a drug class in order to reduce toxicity and increase potency for the target. After synthesizing a variety of analogs for the drug class, she tests these new pharmacologic compounds against a panel of potential targets. Assay results show that there is significant binding to a clustered group of proteins. Upon examining these proteins, she finds that the proteins add a phosphate group to an aromatic amino acid sidechain. Which of the following disorders would most likely be treated by this drug class?
Type in at least one full word to see suggestions list